Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Consumer Advocacy Organizations Challenge Meta Platforms Incs Data Processing Practices Under GDPR

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Navigating the Global Supply Chain: Challenges and Innovations in Zinc and Lead Extraction
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Consumer advocacy organizations within the European Union have recently lodged complaints against Meta Platforms Inc., alleging that the tech behemoth is engaging in unlawful data processing activities on a massive scale. These complaints specifically target Meta’s data gathering techniques, which are purported to violate the tenets of the General Data Protection Regulation (GDPR).

The consumer watchdogs contend that Meta’s “pay-or-consent” option, which allows users to access ad-free versions of Facebook and Instagram by paying a fee, is merely a facade to conceal the true issue of illicit data processing. They argue that this choice fails to elicit genuine and well-informed consent from users.

Ursula Pachl, BEUC’s Deputy Director General, lambasted Meta’s tactics, asserting that the company’s “pay-or-consent” alternative is an endeavor to legitimize its business model by rationalizing extensive commercial surveillance of users.

The grievances against Meta underscore anxieties surrounding its data collection strategies, which contribute to a “surveillance-driven advertising system” that monitors individuals online and amasses substantial quantities of personal information for advertising objectives.

These developments unfold amidst mounting scrutiny on Meta concerning privacy apprehensions and regulatory oversight. The complaints further fuel the ongoing discourse on data privacy, consent, and the lawfulness of data processing practices by major tech corporations such as Meta in the European Union.

META Stock Soars on February 29, 2024: Strong Performance and Positive Price Momentum

On February 29, 2024, META experienced a strong performance in the stock market. According to data from CNN Money, META was trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over a longer period of time.

The price of META shares saw a significant increase on this day, rising by $5.31 since the market last closed. This represents a 1.10% increase in the stock price, closing at $487.05. Investors may have been pleased with this positive price momentum, as it indicates a bullish trend for the stock.

However, it is important to note that the stock experienced a slight drop of $1.20 in after-hours trading. While this drop may be seen as a minor setback, it is not uncommon for stocks to fluctuate in after-hours trading due to lower trading volumes and different market dynamics.

Overall, the performance of META on February 29, 2024, was largely positive, with the stock showing strong price momentum and trading near its 52-week high. Investors will likely be keeping a close eye on META in the coming days to see if the stock can continue its upward trend and build on its recent gains.

META Platforms Inc. Reports Impressive Financial Results for 2023: Revenue Up 15.69%

On February 29, 2024, META Platforms Inc. reported impressive financial results for the past year and fourth quarter. The company’s total revenue for the year stood at $134.90 billion, showing a significant increase of 15.69% compared to the previous year. In the fourth quarter alone, the total revenue was $40.11 billion, marking a 17.47% increase from the previous quarter.

META’s net income also saw substantial growth, with a net income of $39.10 billion for the year, representing a remarkable 68.53% increase from the previous year. In the fourth quarter, the net income was $14.02 billion, showing a 21.01% increase from the previous quarter.

Earnings per share (EPS) for META also showed impressive growth, with an EPS of $14.87 for the year, reflecting a 73.21% increase from the previous year. In the fourth quarter, the EPS was $5.33, showing a 21.52% increase from the previous quarter.

These strong financial results reflect META’s continued success in the digital advertising market and its ability to monetize its large user base effectively. The company’s advertising revenue has been a major driver of its growth, with advertisers increasingly turning to META’s platforms to reach their target audiences.

Investors reacted positively to META’s strong performance, with the company’s stock price likely seeing a boost on February 29, 2024. The impressive revenue, net income, and EPS growth demonstrate that META is a solid investment option for those looking to capitalize on the digital advertising industry’s growth.

Tags: META
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Investings on laptop and finances

Marcus Corporations Strong Financial Performance in Q4 of 2023

Finance_Fiscal (3)

CRH Reports Strong Financial Growth and ShareholderFriendly Initiatives

Biotechnology Stock Market Today (1)

Analyst Recommends Buying Shares of Sarepta Therapeutics with Adjusted Price Target

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com